board of directors

Impactful collaborations with distinguished industry experts help drive the strategic direction of our company.

Edward Whitehorne (Chair)

Former Chairman,
Board of Directors, FHI 360

Patrick Fine, MEd (Vice Chair)

Vice Chair, FHI Clinical Board of Directors  |  Chief Executive Officer, FHI 360

Greg Connors

Consultant


Pamela Myers

Chief Human Resources Officer,
FHI 360

Albert J. Siemens, PhD

Chair, FHI Foundation  |  Former Chairman and Chief Executive Officer, FHI 360

Close Menu
Edward Whitehorne (Chair)

Former Chairman, Board of Directors, FHI 360

With more than three decades of experience both as an active member of the angel investment community and in research and development, Edward Whitehorne brings a diverse blend of financial acumen, investment experience and technical expertise to the FHI Clinical Board of Directors.

An experienced investor with in-depth expertise in informatics, research and development, Mr. Whitehorne joined the FHI 360 Board of Directors in 2000, served as Vice Chair and became Chair in 2014, before retiring from the FHI Board in 2018. Mr. Whitehorne also previously served as Chair of FHI 360’s Executive Committee. He was a founder of Clinical Research International and a founding member of the Atlantis Group and TriState Investment Groups II, III and IV and served on their executive committees.

From 1999 to 2013, Mr. Whitehorne was a member of the Board of Directors of Novella Clinical, Inc., a leader in oncology and medical device clinical trials. In 2013, he led the sale of Novella to Quintiles, Inc. He also serves as a trustee of the FHI Foundation and chairs its investment committee.

Patrick Fine, MEd (Vice Chair)

Vice Chair, FHI Clinical Board of Directors  |  Chief Executive Officer, FHI 360

Along with a deep conviction in the power of people to work together to solve complex human development challenges, Patrick Fine brings 40 years of development experience to his role as the leader of FHI 360. From coordinating a community school in Boston in the 1980s to over 20 years living and working in Africa, as well as numerous assignments in Asia, Eastern Europe and Latin America, Mr. Fine has worked to expand opportunity and empower people.

Before joining FHI 360, Mr. Fine served as the Vice President for Compact Operations at the Millennium Challenge Corporation (MCC) and as Senior Vice President of the Global Learning Group at the Academy for Educational Development (AED).

As a career member of the Foreign Service at the U.S. Agency for International Development (USAID), Mr. Fine served as the Senior Deputy Assistant Administrator in the Africa Bureau and Mission Director in Afghanistan, where he led the rapid expansion of U.S. assistance for reconstruction and development.

Mr. Fine has received numerous awards, including the Distinguished Career Service Award from the U.S. government in 2006. In 2004, the government of Senegal awarded him the Ordre du Mérite for outstanding contributions to education, and in 2011 he received the rank of Commander in the Order of Benin.

Mr. Fine is a former member of the Board of Directors of the Washington, D.C. chapter of the Society for International Development and was a co-founder and former co-chair of the USAID Alumni Association. He served as a member of the Center for Strategic and International Studies (CSIS) Task Force on Women’s and Family Health. In addition to serving as Vice Chair of the FHI Clinical Board of Directors, Mr. Fine currently serves as a member of the Boards of Directors for Made in Durham and the National Peace Corps Association, and he is co-chair of the Board of Directors for the Alliance for International Youth Development.

Greg Connors

Consultant

Greg Connors served as Senior Vice President, Corporate Development at Quintiles during a 24-year career there. He has a track record of more than 30 years of driving corporate growth through merger, acquisition, divestiture and capital markets strategies and transactions. Prior to joining Quintiles, Mr. Connors served as a Senior Manager at EY, an Associate at Chemical Bank and an engineer at IBM. He holds a bachelor’s degree in Mechanical Engineering from Pennsylvania State University and a master’s degree in Business Administration from the University of Chicago.

Pamela Myers

Chief Human Resources Officer, FHI 360

Pamela Myers is responsible for talent management and people functions and systems for all of FHI 360’s offices globally. She has more than 25 years of experience leading human resources and organization development initiatives and functions. She has worked in diverse industries, with experience at a community hospital, pharmaceutical company, clinical laboratory, high-tech firm and a large manufacturer, among others. She has supported human resource efforts in Africa, Asia, Europe, the Middle East, and North and South America.

Ms. Myers’ broad background has encompassed all areas of human resource programs, systems and general administration. She has provided leadership during major organizational changes and restructuring.

A certified Senior Professional in Human Resources, Ms. Myers holds a certificate in organization development from the NTL Institute and is certified in the Myers-Briggs Type Indicator, DISC and other leadership assessment and training programs. Ms. Myers holds an undergraduate degree in health administration and a master’s degree in Business Administration, both from the University of Kentucky.

Albert J. Siemens, PhD

Chair, FHI Foundation  |  Former Chairman and Chief Executive Officer, FHI 360

In addition to serving on the FHI Clinical Board of Directors, Albert J. Siemens, PhD has served on the FHI Foundation’s Board of Trustees since May of 2014 and was elected as its Chair in November 2014. He joined FHI 360 in 1983 with responsibility for the organization’s Clinical Trials Division. In 1998, Dr. Siemens was appointed Chief Executive Officer, a position he held until retirement on May 1, 2014.

In 1986, as Vice President of Research, Siemens was instrumental in the formation of Clinical Research International (CRI), an affiliate of FHI 360 that provided research services to pharmaceutical, biotechnology and medical device companies. He was President of CRI until the company was acquired by ClinTrials Research in late 1990. As Executive Vice President of ClinTrials Research from 1991 through 1997, he was responsible for international corporate expansion and business development. He was elected to the Board of Directors of FHI 360 in 1997 and as Chair of the Board in 2006. He was also CEO of PharmaLinkFHI (renamed Novella Clinical) from 1999 until 2008 and, thereafter, Chairman of the Board until 2013, when the company was acquired by Quintiles, Inc.

Dr. Siemens’ career in medicinal product development began at Pfizer, Inc., where he was responsible for clinical studies of cardiovascular, antibiotic, anti-inflammatory and psychotropic agents in domestic and international divisions of the company. 

Dr. Siemens holds BSc (Pharmacy) and MS degrees from the University of Manitoba, and a PhD in Pharmacology from the University of Toronto. He is a member of the American Society of Clinical Pharmacology and other professional associations and has published on a range of subjects including the drug development process, drug metabolism, drug interactions, drug tolerance, membrane pharmacology and contraceptive evaluation.